Lei Wan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lei Wan has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
Yu Zhao
Postgraduate college, Guangzhou University of Chinese Medicine, Guangzhou 510080, P. R. China
4 shared publications- Jiachun Huang
Guangzhou University of Chinese Medicine, Guangzhou 510405, China
3 shared publications Shihao Wang
The Third Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China
3 shared publicationsShuhua Liu
The Third Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China
3 shared publicationsTongying Chen
The Third Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China
3 shared publicationsHongxing Huang
The Third Clinical Medical College of Guangzhou University of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China
2 shared publications
Latest Publications
- Open Access
- 19 October 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (10) , 1348
Formononetin Protects Osteoblasts Against Oxidative Stress and Attenuates Ovariectomy-Induced Bone Loss in Association with MAPK/AP-1 and NRF2 Signaling
Postmenopausal osteoporosis (PMOP) is associated with estrogen deficiency and oxidative stress (OS), which impair osteoblast survival and osteogenic function. Formononetin (FMN) is a phytoestrogen with antioxidant properties, but its protective effects on osteoblasts under OS and the signaling pathways associated with these effects remain incompletely understood. Here, we evaluated the effects of FMN in ovariectomized (OVX) mice and in a tert-butyl hydroperoxide (t-BOOH)-induced oxidative injury model in MC3T3-E1 cells. Bone microarchitecture, histology, serum OS markers, cell viability, reactive oxygen species (ROS) production, apoptosis, mitochondrial morphology, and osteogenic differentiation were assessed. Network pharmacology, molecular docking, molecular dynamics simulations, RNA sequencing, Western blotting, and pharmacological pathway-modulation experiments were used to investigate signaling changes associated with FMN treatment. FMN attenuated trabecular bone deterioration and systemic oxidative imbalance in OVX mice. In MC3T3-E1 cells, FMN improved cell viability, reduced ROS accumulation and apoptosis, alleviated mitochondrial damage, and preserved osteogenic differentiation following t-BOOH exposure. FMN treatment was accompanied by reduced phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), p38, and c-Jun N-terminal kinase (JNK), together with reduced expression of activator protein 1 (AP-1)-related proteins, including c-Fos, c-Jun, and phosphorylated c-Jun. Pharmacological reactivation of p38/JNK signaling with anisomycin attenuated several antioxidant, anti-apoptotic, and pro-osteogenic effects associated with FMN treatment, whereas nuclear factor erythroid 2-related factor 2 (NRF2) inhibition partially diminished FMN-mediated protection. Collectively, these findings support an association between the protective effects of FMN and modulation of mitogen-activated protein kinase (MAPK)/AP-1 and NRF2-associated signaling.
- 19 October 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (10) , 1348
Open AccessFormononetin Protects Osteoblasts Against Oxidative Stress and Attenuates Ovariectomy-Induced Bone Loss in Association with MAPK/AP-1 and NRF2 Signaling
Postmenopausal osteoporosis (PMOP) is associated with estrogen deficiency and oxidative stress (OS), which impair osteoblast survival and osteogenic function. Formononetin (FMN) is a phytoestrogen with antioxidant properties, but its protective effects on osteoblasts under OS and the signaling pathways associated with these effects remain incompletely understood. Here, we evaluated the effects of FMN in ovariectomized (OVX) mice and in a tert-butyl hydroperoxide (t-BOOH)-induced oxidative injury model in MC3T3-E1 cells. Bone microarchitecture, histology, serum OS markers, cell viability, reactive oxygen species (ROS) production, apoptosis, mitochondrial morphology, and osteogenic differentiation were assessed. Network pharmacology, molecular docking, molecular dynamics simulations, RNA sequencing, Western blotting, and pharmacological pathway-modulation experiments were used to investigate signaling changes associated with FMN treatment. FMN attenuated trabecular bone deterioration and systemic oxidative imbalance in OVX mice. In MC3T3-E1 cells, FMN improved cell viability, reduced ROS accumulation and apoptosis, alleviated mitochondrial damage, and preserved osteogenic differentiation following t-BOOH exposure. FMN treatment was accompanied by reduced phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2), p38, and c-Jun N-terminal kinase (JNK), together with reduced expression of activator protein 1 (AP-1)-related proteins, including c-Fos, c-Jun, and phosphorylated c-Jun. Pharmacological reactivation of p38/JNK signaling with anisomycin attenuated several antioxidant, anti-apoptotic, and pro-osteogenic effects associated with FMN treatment, whereas nuclear factor erythroid 2-related factor 2 (NRF2) inhibition partially diminished FMN-mediated protection. Collectively, these findings support an association between the protective effects of FMN and modulation of mitogen-activated protein kinase (MAPK)/AP-1 and NRF2-associated signaling.
- 6 March 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1019, 178734
Ursolic acid attenuates bone loss by stabilizing osteoblast mitochondrial integrity and inhibiting downstream apoptosis via PI3K-AKT-Bcl2 signaling
- 6 March 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1019, 178734
Ursolic acid attenuates bone loss by stabilizing osteoblast mitochondrial integrity and inhibiting downstream apoptosis via PI3K-AKT-Bcl2 signaling
- Open Access
- 16 January 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e75965
The Diagnostic Value of Image-Based Machine Learning for Osteoporosis: Systematic Review and Meta-Analysis
Background: Osteoporosis (OP) is projected to be a major issue significantly impacting the well-being of middle-aged and old populations. Machine learning (ML) and deep learning (DL) models developed based on medical imaging have enhanced clinicians’ diagnostic accuracy and work efficiency. However, the diagnostic performance of different types of medical imaging for OP has not been systematically assessed. Objective: By summarizing related literature, this study aims to elucidate the role of DL models based on different medical imaging modalities in OP detection. Methods: PubMed, Embase, the Cochrane Library, and Web of Science were systematically searched for studies using ML for the diagnosis of OP based on medical imaging. The final search was conducted on May 16, 2024. The risk of bias in the included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. A bivariate mixed-effects model was applied to perform meta-analyses of sensitivity (SEN) and specificity (SPC), stratified by imaging modality (x-ray, computed tomography [CT], magnetic resonance imaging [MRI]). In addition, subgroup analyses were carried out based on the type of ML algorithm, the method of validation dataset generation, and the anatomical site of assessment. Results: A total of 60 studies comprising 66,195 participants were encompassed in this systematic review and meta-analysis. Among these, 22 studies used x-ray imaging, 37 applied CT imaging, and 3 used MRI for ML-based OP diagnosis. For x-ray–based models, the pooled SEN and SPC for studies focusing on the appendicular skeleton were 0.97 (95% CI 0.83‐0.99) and 0.90 (95% CI 0.75‐0.96), respectively. For studies using the mandible as the target site, SEN and SPC were 0.94 (95% CI 0.89‐0.97) and 0.80 (95% CI 0.56‐0.93), respectively. For those focusing on the lumbar spine, the pooled SEN and SPC were 0.87 (95% CI 0.77‐0.93) and 0.82 (95% CI 0.75‐0.87), respectively. For CT-based models, studies targeting the hip joint reported a pooled SEN and SPC of 0.87 (95% CI 0.83‐0.90) and 0.92 (95% CI 0.81‐0.96), respectively. For the thoracic spine, SEN and SPC were 0.91 (95% CI 0.86‐0.94) and 0.94 (95% CI 0.92‐0.95), respectively, while for the lumbar spine, they were 0.91 (95% CI 0.87‐0.94) and 0.92 (95% CI 0.86‐0.95), respectively. Conclusions: ML based on medical imaging demonstrates high diagnosis accuracy for OP, particularly DL models using x-ray and CT modalities. However, this study included only a limited number of original studies using MRI-based ML, and there remains a lack of adequate external validation across studies, which poses interpretative limitations. Future research should aim to develop artificial intelligence tools with broader applicability and enhanced diagnostic precision.
- 16 January 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e75965
Open AccessThe Diagnostic Value of Image-Based Machine Learning for Osteoporosis: Systematic Review and Meta-Analysis
Background: Osteoporosis (OP) is projected to be a major issue significantly impacting the well-being of middle-aged and old populations. Machine learning (ML) and deep learning (DL) models developed based on medical imaging have enhanced clinicians’ diagnostic accuracy and work efficiency. However, the diagnostic performance of different types of medical imaging for OP has not been systematically assessed. Objective: By summarizing related literature, this study aims to elucidate the role of DL models based on different medical imaging modalities in OP detection. Methods: PubMed, Embase, the Cochrane Library, and Web of Science were systematically searched for studies using ML for the diagnosis of OP based on medical imaging. The final search was conducted on May 16, 2024. The risk of bias in the included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool. A bivariate mixed-effects model was applied to perform meta-analyses of sensitivity (SEN) and specificity (SPC), stratified by imaging modality (x-ray, computed tomography [CT], magnetic resonance imaging [MRI]). In addition, subgroup analyses were carried out based on the type of ML algorithm, the method of validation dataset generation, and the anatomical site of assessment. Results: A total of 60 studies comprising 66,195 participants were encompassed in this systematic review and meta-analysis. Among these, 22 studies used x-ray imaging, 37 applied CT imaging, and 3 used MRI for ML-based OP diagnosis. For x-ray–based models, the pooled SEN and SPC for studies focusing on the appendicular skeleton were 0.97 (95% CI 0.83‐0.99) and 0.90 (95% CI 0.75‐0.96), respectively. For studies using the mandible as the target site, SEN and SPC were 0.94 (95% CI 0.89‐0.97) and 0.80 (95% CI 0.56‐0.93), respectively. For those focusing on the lumbar spine, the pooled SEN and SPC were 0.87 (95% CI 0.77‐0.93) and 0.82 (95% CI 0.75‐0.87), respectively. For CT-based models, studies targeting the hip joint reported a pooled SEN and SPC of 0.87 (95% CI 0.83‐0.90) and 0.92 (95% CI 0.81‐0.96), respectively. For the thoracic spine, SEN and SPC were 0.91 (95% CI 0.86‐0.94) and 0.94 (95% CI 0.92‐0.95), respectively, while for the lumbar spine, they were 0.91 (95% CI 0.87‐0.94) and 0.92 (95% CI 0.86‐0.95), respectively. Conclusions: ML based on medical imaging demonstrates high diagnosis accuracy for OP, particularly DL models using x-ray and CT modalities. However, this study included only a limited number of original studies using MRI-based ML, and there remains a lack of adequate external validation across studies, which poses interpretative limitations. Future research should aim to develop artificial intelligence tools with broader applicability and enhanced diagnostic precision.
- Open Access
- 8 January 2026
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 30 (1) , e70978
The Effect of Multipoint Injection Strategies of BMSCs on Repairing Cartilage Defects of the Knee Joint
Bone marrow‐derived mesenchymal stem cells (BMSCs) are extensively utilised in tissue engineering and regenerative medicine due to their multipotent differentiation capabilities. However, the therapeutic efficacy of BMSCs is highly dependent on the transplantation route. This study aimed to compare the efficacy of commonly used BMSCs transplantation methods and identify the optimal delivery approach for cartilage repair. Our results demonstrated that all transplantation methods could significantly suppress pro‐inflammatory factors, including IL‐1β, iNOS, and MMP‐9, while enhancing the activity of the key antioxidant enzyme superoxide dismutase (SOD). The intra‐articular injection group exhibited the most substantial anti‐inflammatory and antioxidant improvements. In vivo tracking experiments revealed that BMSCs from all groups were capable of homing to the cartilage defect site at 4 weeks post‐modelling. Notably, the intra‐articular injection group recruited the highest number of BMSCs to the defect area. Further histological analysis indicated that the joints treated with intra‐articular injection displayed superior cartilage regeneration, characterised by a smooth tissue surface and coloration closely resembling adjacent native cartilage. In conclusion, while all tested BMSCs transplantation approaches contributed to cartilage repair, intra‐articular injection demonstrated the most favourable therapeutic outcomes.
- 8 January 2026
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 30 (1) , e70978
Open AccessThe Effect of Multipoint Injection Strategies of BMSCs on Repairing Cartilage Defects of the Knee Joint
Bone marrow‐derived mesenchymal stem cells (BMSCs) are extensively utilised in tissue engineering and regenerative medicine due to their multipotent differentiation capabilities. However, the therapeutic efficacy of BMSCs is highly dependent on the transplantation route. This study aimed to compare the efficacy of commonly used BMSCs transplantation methods and identify the optimal delivery approach for cartilage repair. Our results demonstrated that all transplantation methods could significantly suppress pro‐inflammatory factors, including IL‐1β, iNOS, and MMP‐9, while enhancing the activity of the key antioxidant enzyme superoxide dismutase (SOD). The intra‐articular injection group exhibited the most substantial anti‐inflammatory and antioxidant improvements. In vivo tracking experiments revealed that BMSCs from all groups were capable of homing to the cartilage defect site at 4 weeks post‐modelling. Notably, the intra‐articular injection group recruited the highest number of BMSCs to the defect area. Further histological analysis indicated that the joints treated with intra‐articular injection displayed superior cartilage regeneration, characterised by a smooth tissue surface and coloration closely resembling adjacent native cartilage. In conclusion, while all tested BMSCs transplantation approaches contributed to cartilage repair, intra‐articular injection demonstrated the most favourable therapeutic outcomes.
- Open Access
- 8 August 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1451695
Identification of miRNAs related to osteoporosis by high-throughput sequencing
Background: Osteoporosis is a major health issue. MicroRNAs (miRNAs) play multiple roles in regulating cell growth and development. High-throughput sequencing technology is widely used nowadays.Objective: To screen for and validate miRNAs associated with osteoporosis.Method: Bone specimens from patients with (n = 3) and without (n = 3) osteoporosis were collected. High-throughput sequencing was used to screen for miRNAs that were then analyzed using volcano maps, Wayne maps, gene ontology (GO) analysis, and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Confirmation of the miRNAs was done using qRT-PCR.Results: The analysis of sequencing showed that there were 12 miRNAs that were down-regulated and five miRNAs that were upregulated in osteoporosis. GO and KEGG identified these miRNAs as being associated with bone metabolism. The qRT-PCR results showed that miR-140-5p, miR-127-3p, miR-199b-5p, miR-181a-5p, miR-181d-5p, and miR-542-3p exhibited a decrease of 2.27-, 3.00-, 3.48-, 2.67-, 2.41-, and 1.98-fold (all P < 0.05) in osteoporosis compared to controls. Conversely, miR-486-3p and miR-486-5p demonstrated an increase of 2.17- and 3.89-fold (P < 0.05) (all P < 0.05).Conclusion: This study utilized high-throughput sequencing to detect miRNAs that were expressed differently in individuals with osteoporosis. In osteoporosis, six miRNAs (miR-140-5p, miR-127-3p, miR-199b-5p, miR-181a-5p, miR-181d-5p, and miR-542) were found to have decreased expression, whereas two miRNAs (miR-486-3p and miR-486-5p) were found to have increased expression. The initial manifestation of various miRNAs might serve as predictive indicators and potentially anticipate the progression of osteoporosis.
- 8 August 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1451695
Open AccessIdentification of miRNAs related to osteoporosis by high-throughput sequencing
Background: Osteoporosis is a major health issue. MicroRNAs (miRNAs) play multiple roles in regulating cell growth and development. High-throughput sequencing technology is widely used nowadays.Objective: To screen for and validate miRNAs associated with osteoporosis.Method: Bone specimens from patients with (n = 3) and without (n = 3) osteoporosis were collected. High-throughput sequencing was used to screen for miRNAs that were then analyzed using volcano maps, Wayne maps, gene ontology (GO) analysis, and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Confirmation of the miRNAs was done using qRT-PCR.Results: The analysis of sequencing showed that there were 12 miRNAs that were down-regulated and five miRNAs that were upregulated in osteoporosis. GO and KEGG identified these miRNAs as being associated with bone metabolism. The qRT-PCR results showed that miR-140-5p, miR-127-3p, miR-199b-5p, miR-181a-5p, miR-181d-5p, and miR-542-3p exhibited a decrease of 2.27-, 3.00-, 3.48-, 2.67-, 2.41-, and 1.98-fold (all P < 0.05) in osteoporosis compared to controls. Conversely, miR-486-3p and miR-486-5p demonstrated an increase of 2.17- and 3.89-fold (P < 0.05) (all P < 0.05).Conclusion: This study utilized high-throughput sequencing to detect miRNAs that were expressed differently in individuals with osteoporosis. In osteoporosis, six miRNAs (miR-140-5p, miR-127-3p, miR-199b-5p, miR-181a-5p, miR-181d-5p, and miR-542) were found to have decreased expression, whereas two miRNAs (miR-486-3p and miR-486-5p) were found to have increased expression. The initial manifestation of various miRNAs might serve as predictive indicators and potentially anticipate the progression of osteoporosis.
- Open Access
- 23 May 2024
- Published by Elsevier in SLAS Technology
- Vol. 29 (4) , 100149
Machine-learning models for diagnosis of rotator cuff tears in osteoporosis patients based on anteroposterior X-rays of the shoulder joint
- 23 May 2024
- Published by Elsevier in SLAS Technology
- Vol. 29 (4) , 100149
Open AccessMachine-learning models for diagnosis of rotator cuff tears in osteoporosis patients based on anteroposterior X-rays of the shoulder joint
- Open Access
- 2 August 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 908043
Exploring the effect of the “quaternary regulation” theory of “peripheral nerve-angiogenesis-osteoclast-osteogenesis” on osteoporosis based on neuropeptides
Osteoporosis is a common bone metabolic disease among the middle-aged and elderly, with its high incidence rate and a major cause of disability and mortality. Early studies found that bone metabolic homeostasis is achieved through osteogenesis-osteoclast coupling. Although current anti-osteoporosis drugs can attenuate bone loss caused by aging, they present specific side effects. With the discovery of CD31hi Emcnhi blood vessels in 2014, the effect of H-type blood vessels on bone metabolism has been valued by researchers, and the ternary regulation theory of bone metabolism of “Angiogenesis-Osteoclast-Osteogenesis” has also been recognized. Nowadays, more studies have confirmed that peripheral nerves substantially impact bone metabolism. However, due to the complex function of peripheral nerves, the crosstalk mechanism of “Peripheral nerve-Angiogenesis-Osteoclast-Osteogenesis” has not yet been fully revealed. Neuropeptide serves as signaling molecules secreted by peripheral nerves that regulate blood vessels, osteoblasts, and osteoclasts’ functions. It is likely to be the breakthrough point of the quaternary regulation theory of “Peripheral nerve-Angiogenesis-Osteoclast-Osteogenesis”. Here, we discuss the effect of peripheral nerves on osteoporosis based on neuropeptides.
- 2 August 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 908043
Open AccessExploring the effect of the “quaternary regulation” theory of “peripheral nerve-angiogenesis-osteoclast-osteogenesis” on osteoporosis based on neuropeptides
Osteoporosis is a common bone metabolic disease among the middle-aged and elderly, with its high incidence rate and a major cause of disability and mortality. Early studies found that bone metabolic homeostasis is achieved through osteogenesis-osteoclast coupling. Although current anti-osteoporosis drugs can attenuate bone loss caused by aging, they present specific side effects. With the discovery of CD31hi Emcnhi blood vessels in 2014, the effect of H-type blood vessels on bone metabolism has been valued by researchers, and the ternary regulation theory of bone metabolism of “Angiogenesis-Osteoclast-Osteogenesis” has also been recognized. Nowadays, more studies have confirmed that peripheral nerves substantially impact bone metabolism. However, due to the complex function of peripheral nerves, the crosstalk mechanism of “Peripheral nerve-Angiogenesis-Osteoclast-Osteogenesis” has not yet been fully revealed. Neuropeptide serves as signaling molecules secreted by peripheral nerves that regulate blood vessels, osteoblasts, and osteoclasts’ functions. It is likely to be the breakthrough point of the quaternary regulation theory of “Peripheral nerve-Angiogenesis-Osteoclast-Osteogenesis”. Here, we discuss the effect of peripheral nerves on osteoporosis based on neuropeptides.
- Open Access
- 1 January 2022
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 10 (2) , 64
Cistanoside A promotes osteogenesis of primary osteoblasts by alleviating apoptosis and activating autophagy through involvement of the Wnt/β-catenin signal pathway
Cistanoside A promotes osteogenesis of primary osteoblasts by alleviating apoptosis and activating autophagy through involvement of the Wnt/β-catenin signal pathway Tongying Chen, Fenghe Gao, Dan Luo, Shihao Wang, Yu Zhao, Shuhua Liu, Jiachun Huang, Yanping Lin, Zhihai Zhang, Hongxing Huang, Lei Wan
- 1 January 2022
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 10 (2) , 64
Open AccessCistanoside A promotes osteogenesis of primary osteoblasts by alleviating apoptosis and activating autophagy through involvement of the Wnt/β-catenin signal pathway
Cistanoside A promotes osteogenesis of primary osteoblasts by alleviating apoptosis and activating autophagy through involvement of the Wnt/β-catenin signal pathway Tongying Chen, Fenghe Gao, Dan Luo, Shihao Wang, Yu Zhao, Shuhua Liu, Jiachun Huang, Yanping Lin, Zhihai Zhang, Hongxing Huang, Lei Wan
- Open Access
- 26 March 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (12) , e25197
The efficacy and safety of traditional Chinese medicine's tonifying-kidney, strengthening-spleen, and invigorating-blood circulation (Bushen-Jianpi-Huoxue) principle for type 2 diabetes mellitus with osteoporosis
Background: Type 2 diabetes mellitus (T2D) and osteoporosis (OP) often coexist, and both are systemic metabolic diseases and seriously increase the risk of fragility fracture. However, there is no specific Western medicine for the treatment of T2D with OP (T2DOP). As reported in clinical and experimental studies, traditional Chinese medicine (TCM) based on principle of tonifying-kidney, strengthening-spleen, and invigorating blood circulation (Bushen-Jianpi-Huoxue) (BSJPHX) has significant efficacy against T2DOP. This protocol will be designed for a systematic review and meta-analysis to assess the efficacy and safety of TCM BSJPHX principle in the treatment of T2DOP. Methods: All relevant randomized controlled trials (RCTs) related to TCM therapies conducted in BSJPHX principle for T2DOP will be searched in the 8 electronic databases: PubMed, Cochrane Library, Wed of Science, EMBASE, Chinese National Knowledge Infrastructure Database (CNKI), Chinese Biomedical Literatures Database (CBM), Chinese Scientific Journal Database (VIP), Wanfang Database, from inception to October 2020. The main outcomes will contain: fasting blood glucose (FPG), 2 hours postprandial blood glucose (2hPG), glycosylated hemoglobin (HbA1c), serum calcium, bone mineral density (BMD), TCM syndrome integral, and the additional outcomes will consist of visual analog scale (VAS), and adverse events. Two reviewers will independently carry out literature search, data selection and synthesis, and literature quality assessment. In case of any dispute, it will be settled by group discussion. Assessment of risk of bias, reporting bias, and data synthesis would be performed with Review Manager software (Rev-Man 5.3). Result: This study will collate and summarize the various current evidences of TCM BSJPHX principle for T2DOP. Conclusion: This study will offer convincing evidence for judging the efficacy and safety of TCM BSJPHX principle for T2DOP. PROSPERO registration number: CRD42020218877.
- 26 March 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (12) , e25197
Open AccessThe efficacy and safety of traditional Chinese medicine's tonifying-kidney, strengthening-spleen, and invigorating-blood circulation (Bushen-Jianpi-Huoxue) principle for type 2 diabetes mellitus with osteoporosis
Background: Type 2 diabetes mellitus (T2D) and osteoporosis (OP) often coexist, and both are systemic metabolic diseases and seriously increase the risk of fragility fracture. However, there is no specific Western medicine for the treatment of T2D with OP (T2DOP). As reported in clinical and experimental studies, traditional Chinese medicine (TCM) based on principle of tonifying-kidney, strengthening-spleen, and invigorating blood circulation (Bushen-Jianpi-Huoxue) (BSJPHX) has significant efficacy against T2DOP. This protocol will be designed for a systematic review and meta-analysis to assess the efficacy and safety of TCM BSJPHX principle in the treatment of T2DOP. Methods: All relevant randomized controlled trials (RCTs) related to TCM therapies conducted in BSJPHX principle for T2DOP will be searched in the 8 electronic databases: PubMed, Cochrane Library, Wed of Science, EMBASE, Chinese National Knowledge Infrastructure Database (CNKI), Chinese Biomedical Literatures Database (CBM), Chinese Scientific Journal Database (VIP), Wanfang Database, from inception to October 2020. The main outcomes will contain: fasting blood glucose (FPG), 2 hours postprandial blood glucose (2hPG), glycosylated hemoglobin (HbA1c), serum calcium, bone mineral density (BMD), TCM syndrome integral, and the additional outcomes will consist of visual analog scale (VAS), and adverse events. Two reviewers will independently carry out literature search, data selection and synthesis, and literature quality assessment. In case of any dispute, it will be settled by group discussion. Assessment of risk of bias, reporting bias, and data synthesis would be performed with Review Manager software (Rev-Man 5.3). Result: This study will collate and summarize the various current evidences of TCM BSJPHX principle for T2DOP. Conclusion: This study will offer convincing evidence for judging the efficacy and safety of TCM BSJPHX principle for T2DOP. PROSPERO registration number: CRD42020218877.
- Open Access
- 31 May 2019
- Published by Springer Nature in Journal of Biological Engineering
- Vol. 13 (1) , 50
Expression profile analysis of long non-coding RNA in skeletal muscle of osteoporosis by microarray and bioinformatics
Osteoporosis (OP) is a condition featured by bone mass loss and bone tissue microarchitectural alterations due to impaired tissue homeostasis favoring excessive bone resorption versus deposition. The trigger of such an impairment and the downstream molecular pathways involved are yet to be clarified. Long non-coding RNA (lncRNA) plays a role in gene transcription, protein expression and epigenetic regulation; and altered expression results in immune or metabolism related desease development. To determine whether lncRNAs are involved in osteoporosis, we analyzed the expression profile of lncRNAs and mRNAs in osteoporosis. Three pairs of osteoporosis patients (OP group) and healthy people controls (NC group) were screened by microarray. Quantitative polymerase chain reaction (qRT-PCR) was performed to confirm dysregulated lncRNA expressions in 5 pairs of OP and NC group tissues samples. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to construct the lncRNA-mRNA co-expression network. Through co-expression analysis, differently expressed transcripts were divided into modules, and lncRNAs were functionally annotated. We further analyzed the clinical significance of crucial lncRNAs from modules in public data. Finally, the expression of five lncRNAs, CUST_44695_PI430048170-GeneSymbol:CTA-384D8.35;CUST_39447_PI430048170,CUST_73298_PI430048170,CUST_108340_PI430048170,CUST_118927_PI430048170,this four lncRNAs have not been annotation genes and have not found GeneSymbols, and by quantitative RT-PCR, which may be associated with osteoporosis patients’ overall survival. Analysis of this study revealed that dysregulated lncRNAs and mRNAs in osteoporosis patients and health people controls could affect the immune or metabolism system and musculoskeletal cell differentiation. The biological functions of those lncRNAs need to be further validated.
- 31 May 2019
- Published by Springer Nature in Journal of Biological Engineering
- Vol. 13 (1) , 50
Open AccessExpression profile analysis of long non-coding RNA in skeletal muscle of osteoporosis by microarray and bioinformatics
Osteoporosis (OP) is a condition featured by bone mass loss and bone tissue microarchitectural alterations due to impaired tissue homeostasis favoring excessive bone resorption versus deposition. The trigger of such an impairment and the downstream molecular pathways involved are yet to be clarified. Long non-coding RNA (lncRNA) plays a role in gene transcription, protein expression and epigenetic regulation; and altered expression results in immune or metabolism related desease development. To determine whether lncRNAs are involved in osteoporosis, we analyzed the expression profile of lncRNAs and mRNAs in osteoporosis. Three pairs of osteoporosis patients (OP group) and healthy people controls (NC group) were screened by microarray. Quantitative polymerase chain reaction (qRT-PCR) was performed to confirm dysregulated lncRNA expressions in 5 pairs of OP and NC group tissues samples. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses were performed to construct the lncRNA-mRNA co-expression network. Through co-expression analysis, differently expressed transcripts were divided into modules, and lncRNAs were functionally annotated. We further analyzed the clinical significance of crucial lncRNAs from modules in public data. Finally, the expression of five lncRNAs, CUST_44695_PI430048170-GeneSymbol:CTA-384D8.35;CUST_39447_PI430048170,CUST_73298_PI430048170,CUST_108340_PI430048170,CUST_118927_PI430048170,this four lncRNAs have not been annotation genes and have not found GeneSymbols, and by quantitative RT-PCR, which may be associated with osteoporosis patients’ overall survival. Analysis of this study revealed that dysregulated lncRNAs and mRNAs in osteoporosis patients and health people controls could affect the immune or metabolism system and musculoskeletal cell differentiation. The biological functions of those lncRNAs need to be further validated.